Metraipolis › archive › dc_df396b18c5e2

Who can safely discontinue lifelong follow-up among patients with sporadic pheochromocytoma and paraganglioma? — Europe PMC PMID:41781348

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41781348
DOI
10.1111/joim.70080
License (as archived)
solo-consultazione
Archived
2026-11-05T03:44:00.204Z
SHA-256 of the archived text
782f3835d3b1e0da029c1c52230cc9d03de3b7288b1e5b4fb9ee54106a5f5f11
Stable URL of this page
https://metraipolis.com/documento/dc_df396b18c5e2

How to cite

Who can safely discontinue lifelong follow-up among patients with sporadic pheochromocytoma and paraganglioma? — Europe PMC PMID:41781348 — Europe PMC (en), https://europepmc.org/article/MED/41781348 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df396b18c5e2 (Metraipolis archive dc_df396b18c5e2, sha256 782f3835d3b1e0da029c1c52230cc9d03de3b7288b1e5b4fb9ee54106a5f5f11)
BibTeX
@misc{dcdf396b18c5e2,
  title = {Who can safely discontinue lifelong follow-up among patients with sporadic pheochromocytoma and paraganglioma? — Europe PMC PMID:41781348},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41781348},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df396b18c5e2; sha256 782f3835d3b1e0da029c1c52230cc9d03de3b7288b1e5b4fb9ee54106a5f5f11},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41781348. Agents can read the archived copy with the MCP tool read_document.